Loading…
Glucose Metabolism Disorders and Parkinson's Disease: Coincidence or Indicator of Dysautonomia?
Parkinson's disease (PD) and type 2 diabetes mellitus (T2DM) are both age-related diseases. Evidence from recent studies suggests a link between them. The existence of an interaction between autonomic nervous system dysfunction and the dysregulation of glucose metabolism is one of the proposed...
Saved in:
Published in: | Healthcare (Basel) 2024-12, Vol.12 (23), p.2462 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c379t-421b5c533e759cbf0b3e937cf182419409cf97a80a1396540b795859c484cb33 |
container_end_page | |
container_issue | 23 |
container_start_page | 2462 |
container_title | Healthcare (Basel) |
container_volume | 12 |
creator | Chmiela, Tomasz Jarosz-Chobot, Przemysława Gorzkowska, Agnieszka |
description | Parkinson's disease (PD) and type 2 diabetes mellitus (T2DM) are both age-related diseases. Evidence from recent studies suggests a link between them. The existence of an interaction between autonomic nervous system dysfunction and the dysregulation of glucose metabolism is one of the proposed mechanisms to explain the complicated relationship between these diseases. The aims of this study are to assess the incidence of glycemic dysregulation in people with PD and to identify clinical factors that may predispose patients with PD to the occurrence of metabolic disturbances.
In total, 35 individuals diagnosed with PD and 20 healthy control subjects matched in terms of age and gender participated in a study consisting of clinical and biometric assessments along with 14 days of continuous glucose monitoring (CGM) using the Freestyle Libre system. In the group of patients with PD, a comparative analysis was performed between patients with and without autonomic dysfunction. The severity of autonomic dysfunction was assessed using the SCOPA-AUT.
: Participants diagnosed with PD demonstrated a trend toward lower morning glucose levels compared to the control group. PD patients with autonomic symptoms had greater glucose variability and a deeper trend toward lower glucose levels in the mornings. The presence of autonomic dysfunction, especially orthostatic hypotension and micturition disturbance, and the severity of autonomic symptoms were associated with greater glycemic variability.
: The occurrence of autonomic disorders in the course of Parkinson's disease predisposes patients to more profound glycemic dysregulation. |
doi_str_mv | 10.3390/healthcare12232462 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11641510</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A819950698</galeid><sourcerecordid>A819950698</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-421b5c533e759cbf0b3e937cf182419409cf97a80a1396540b795859c484cb33</originalsourceid><addsrcrecordid>eNptkl1PHSEQhompUaP-gV40m_SivTkKDOxCb4w5tmqiaS-8Jyw768HugoVdE_99OfGjaoUQJszzvjBkCPnI6AGApocrtMO0cjYh4xy4qPkG2eGcNwtNgX94EW-T_ZxvaBmagQK5RbZB10pSBTvEnA6zixmrS5xsGwefx-rE55g6TLmyoat-2fTbhxzDl7zOoM34rVpGH5zvMDisYqrOQ-ednUoU--rkPtt5iiGO3h7tkc3eDhn3H_ddcvXj-9XybHHx8_R8eXyxcNDoaSE4a6WTANhI7dqetoAaGtczxQXTgmrX68Yqall5uxS0bbRUBRVKuBZglxw92N7O7YidwzAlO5jb5Eeb7k203rzOBL8y1_HOMFYLJhktDl8fHVL8M2OezOizw2GwAeOcDTBR67KoLujnN-hNnFMo5a0p0JwxBf-oazug8aGP5WK3NjXHimktaa1VoQ7eocrscPQuBux9OX8l4A8Cl2LOCfvnIhk1684w_3dGEX16-T3Pkqc-gL93DLTx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3143921183</pqid></control><display><type>article</type><title>Glucose Metabolism Disorders and Parkinson's Disease: Coincidence or Indicator of Dysautonomia?</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Chmiela, Tomasz ; Jarosz-Chobot, Przemysława ; Gorzkowska, Agnieszka</creator><creatorcontrib>Chmiela, Tomasz ; Jarosz-Chobot, Przemysława ; Gorzkowska, Agnieszka</creatorcontrib><description>Parkinson's disease (PD) and type 2 diabetes mellitus (T2DM) are both age-related diseases. Evidence from recent studies suggests a link between them. The existence of an interaction between autonomic nervous system dysfunction and the dysregulation of glucose metabolism is one of the proposed mechanisms to explain the complicated relationship between these diseases. The aims of this study are to assess the incidence of glycemic dysregulation in people with PD and to identify clinical factors that may predispose patients with PD to the occurrence of metabolic disturbances.
In total, 35 individuals diagnosed with PD and 20 healthy control subjects matched in terms of age and gender participated in a study consisting of clinical and biometric assessments along with 14 days of continuous glucose monitoring (CGM) using the Freestyle Libre system. In the group of patients with PD, a comparative analysis was performed between patients with and without autonomic dysfunction. The severity of autonomic dysfunction was assessed using the SCOPA-AUT.
: Participants diagnosed with PD demonstrated a trend toward lower morning glucose levels compared to the control group. PD patients with autonomic symptoms had greater glucose variability and a deeper trend toward lower glucose levels in the mornings. The presence of autonomic dysfunction, especially orthostatic hypotension and micturition disturbance, and the severity of autonomic symptoms were associated with greater glycemic variability.
: The occurrence of autonomic disorders in the course of Parkinson's disease predisposes patients to more profound glycemic dysregulation.</description><identifier>ISSN: 2227-9032</identifier><identifier>EISSN: 2227-9032</identifier><identifier>DOI: 10.3390/healthcare12232462</identifier><identifier>PMID: 39685083</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Autonomic neuropathies ; Chronic illnesses ; Complications and side effects ; Consent ; Dementia ; Development and progression ; Diabetes ; Disease ; Glucose monitoring ; Heavy metals ; Hemoglobin ; Insulin resistance ; Kinases ; Metabolism ; Movement disorders ; Nervous system ; Neurodegeneration ; Oxidative stress ; Parkinson's disease ; Proteins ; Risk factors ; Sensors ; Trends ; Type 2 diabetes</subject><ispartof>Healthcare (Basel), 2024-12, Vol.12 (23), p.2462</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c379t-421b5c533e759cbf0b3e937cf182419409cf97a80a1396540b795859c484cb33</cites><orcidid>0000-0001-6022-7731 ; 0000-0001-5081-8343</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3143921183/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3143921183?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39685083$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chmiela, Tomasz</creatorcontrib><creatorcontrib>Jarosz-Chobot, Przemysława</creatorcontrib><creatorcontrib>Gorzkowska, Agnieszka</creatorcontrib><title>Glucose Metabolism Disorders and Parkinson's Disease: Coincidence or Indicator of Dysautonomia?</title><title>Healthcare (Basel)</title><addtitle>Healthcare (Basel)</addtitle><description>Parkinson's disease (PD) and type 2 diabetes mellitus (T2DM) are both age-related diseases. Evidence from recent studies suggests a link between them. The existence of an interaction between autonomic nervous system dysfunction and the dysregulation of glucose metabolism is one of the proposed mechanisms to explain the complicated relationship between these diseases. The aims of this study are to assess the incidence of glycemic dysregulation in people with PD and to identify clinical factors that may predispose patients with PD to the occurrence of metabolic disturbances.
In total, 35 individuals diagnosed with PD and 20 healthy control subjects matched in terms of age and gender participated in a study consisting of clinical and biometric assessments along with 14 days of continuous glucose monitoring (CGM) using the Freestyle Libre system. In the group of patients with PD, a comparative analysis was performed between patients with and without autonomic dysfunction. The severity of autonomic dysfunction was assessed using the SCOPA-AUT.
: Participants diagnosed with PD demonstrated a trend toward lower morning glucose levels compared to the control group. PD patients with autonomic symptoms had greater glucose variability and a deeper trend toward lower glucose levels in the mornings. The presence of autonomic dysfunction, especially orthostatic hypotension and micturition disturbance, and the severity of autonomic symptoms were associated with greater glycemic variability.
: The occurrence of autonomic disorders in the course of Parkinson's disease predisposes patients to more profound glycemic dysregulation.</description><subject>Autonomic neuropathies</subject><subject>Chronic illnesses</subject><subject>Complications and side effects</subject><subject>Consent</subject><subject>Dementia</subject><subject>Development and progression</subject><subject>Diabetes</subject><subject>Disease</subject><subject>Glucose monitoring</subject><subject>Heavy metals</subject><subject>Hemoglobin</subject><subject>Insulin resistance</subject><subject>Kinases</subject><subject>Metabolism</subject><subject>Movement disorders</subject><subject>Nervous system</subject><subject>Neurodegeneration</subject><subject>Oxidative stress</subject><subject>Parkinson's disease</subject><subject>Proteins</subject><subject>Risk factors</subject><subject>Sensors</subject><subject>Trends</subject><subject>Type 2 diabetes</subject><issn>2227-9032</issn><issn>2227-9032</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkl1PHSEQhompUaP-gV40m_SivTkKDOxCb4w5tmqiaS-8Jyw768HugoVdE_99OfGjaoUQJszzvjBkCPnI6AGApocrtMO0cjYh4xy4qPkG2eGcNwtNgX94EW-T_ZxvaBmagQK5RbZB10pSBTvEnA6zixmrS5xsGwefx-rE55g6TLmyoat-2fTbhxzDl7zOoM34rVpGH5zvMDisYqrOQ-ednUoU--rkPtt5iiGO3h7tkc3eDhn3H_ddcvXj-9XybHHx8_R8eXyxcNDoaSE4a6WTANhI7dqetoAaGtczxQXTgmrX68Yqall5uxS0bbRUBRVKuBZglxw92N7O7YidwzAlO5jb5Eeb7k203rzOBL8y1_HOMFYLJhktDl8fHVL8M2OezOizw2GwAeOcDTBR67KoLujnN-hNnFMo5a0p0JwxBf-oazug8aGP5WK3NjXHimktaa1VoQ7eocrscPQuBux9OX8l4A8Cl2LOCfvnIhk1684w_3dGEX16-T3Pkqc-gL93DLTx</recordid><startdate>20241206</startdate><enddate>20241206</enddate><creator>Chmiela, Tomasz</creator><creator>Jarosz-Chobot, Przemysława</creator><creator>Gorzkowska, Agnieszka</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>KB0</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6022-7731</orcidid><orcidid>https://orcid.org/0000-0001-5081-8343</orcidid></search><sort><creationdate>20241206</creationdate><title>Glucose Metabolism Disorders and Parkinson's Disease: Coincidence or Indicator of Dysautonomia?</title><author>Chmiela, Tomasz ; Jarosz-Chobot, Przemysława ; Gorzkowska, Agnieszka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-421b5c533e759cbf0b3e937cf182419409cf97a80a1396540b795859c484cb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Autonomic neuropathies</topic><topic>Chronic illnesses</topic><topic>Complications and side effects</topic><topic>Consent</topic><topic>Dementia</topic><topic>Development and progression</topic><topic>Diabetes</topic><topic>Disease</topic><topic>Glucose monitoring</topic><topic>Heavy metals</topic><topic>Hemoglobin</topic><topic>Insulin resistance</topic><topic>Kinases</topic><topic>Metabolism</topic><topic>Movement disorders</topic><topic>Nervous system</topic><topic>Neurodegeneration</topic><topic>Oxidative stress</topic><topic>Parkinson's disease</topic><topic>Proteins</topic><topic>Risk factors</topic><topic>Sensors</topic><topic>Trends</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chmiela, Tomasz</creatorcontrib><creatorcontrib>Jarosz-Chobot, Przemysława</creatorcontrib><creatorcontrib>Gorzkowska, Agnieszka</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Healthcare (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chmiela, Tomasz</au><au>Jarosz-Chobot, Przemysława</au><au>Gorzkowska, Agnieszka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucose Metabolism Disorders and Parkinson's Disease: Coincidence or Indicator of Dysautonomia?</atitle><jtitle>Healthcare (Basel)</jtitle><addtitle>Healthcare (Basel)</addtitle><date>2024-12-06</date><risdate>2024</risdate><volume>12</volume><issue>23</issue><spage>2462</spage><pages>2462-</pages><issn>2227-9032</issn><eissn>2227-9032</eissn><abstract>Parkinson's disease (PD) and type 2 diabetes mellitus (T2DM) are both age-related diseases. Evidence from recent studies suggests a link between them. The existence of an interaction between autonomic nervous system dysfunction and the dysregulation of glucose metabolism is one of the proposed mechanisms to explain the complicated relationship between these diseases. The aims of this study are to assess the incidence of glycemic dysregulation in people with PD and to identify clinical factors that may predispose patients with PD to the occurrence of metabolic disturbances.
In total, 35 individuals diagnosed with PD and 20 healthy control subjects matched in terms of age and gender participated in a study consisting of clinical and biometric assessments along with 14 days of continuous glucose monitoring (CGM) using the Freestyle Libre system. In the group of patients with PD, a comparative analysis was performed between patients with and without autonomic dysfunction. The severity of autonomic dysfunction was assessed using the SCOPA-AUT.
: Participants diagnosed with PD demonstrated a trend toward lower morning glucose levels compared to the control group. PD patients with autonomic symptoms had greater glucose variability and a deeper trend toward lower glucose levels in the mornings. The presence of autonomic dysfunction, especially orthostatic hypotension and micturition disturbance, and the severity of autonomic symptoms were associated with greater glycemic variability.
: The occurrence of autonomic disorders in the course of Parkinson's disease predisposes patients to more profound glycemic dysregulation.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39685083</pmid><doi>10.3390/healthcare12232462</doi><orcidid>https://orcid.org/0000-0001-6022-7731</orcidid><orcidid>https://orcid.org/0000-0001-5081-8343</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2227-9032 |
ispartof | Healthcare (Basel), 2024-12, Vol.12 (23), p.2462 |
issn | 2227-9032 2227-9032 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11641510 |
source | Open Access: PubMed Central; Publicly Available Content Database |
subjects | Autonomic neuropathies Chronic illnesses Complications and side effects Consent Dementia Development and progression Diabetes Disease Glucose monitoring Heavy metals Hemoglobin Insulin resistance Kinases Metabolism Movement disorders Nervous system Neurodegeneration Oxidative stress Parkinson's disease Proteins Risk factors Sensors Trends Type 2 diabetes |
title | Glucose Metabolism Disorders and Parkinson's Disease: Coincidence or Indicator of Dysautonomia? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A44%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucose%20Metabolism%20Disorders%20and%20Parkinson's%20Disease:%20Coincidence%20or%20Indicator%20of%20Dysautonomia?&rft.jtitle=Healthcare%20(Basel)&rft.au=Chmiela,%20Tomasz&rft.date=2024-12-06&rft.volume=12&rft.issue=23&rft.spage=2462&rft.pages=2462-&rft.issn=2227-9032&rft.eissn=2227-9032&rft_id=info:doi/10.3390/healthcare12232462&rft_dat=%3Cgale_pubme%3EA819950698%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c379t-421b5c533e759cbf0b3e937cf182419409cf97a80a1396540b795859c484cb33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3143921183&rft_id=info:pmid/39685083&rft_galeid=A819950698&rfr_iscdi=true |